Clinical Trial Update: Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pentostatin, bendamustine, and ofatumumab for chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• Ofatumumab (ofatumumab)
• Pentostatin (pentostatin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Chronic Lymphocytic Leukemia, B-Cell Non-Hodgkin's Lymphoma | Phase 1 | Status: TERMINATED